la profilassi, la diagnosi e la scelta della terapia ...€¦ · la profilassi, la diagnosi e la...
TRANSCRIPT
-
Fabio Tumietto
Programma Aziendale Epidemiologia e Controllo del Rischio Infettivo Correlato alle Organizzazioni Sanitarie
-
Clinica Malattie Infettive - Bologna
La profilassi, la diagnosi e la scelta della terapia antibiotica
SEPSI E INFEZIONI IN GRAVIDANZA 17-18 ottobre 2014
-
Prevalence of antimicrobial use (percentage of patients receiving at least one antimicrobial agent) in European hospitals, by country, ECDC PPS 2011–2012
-
He observed that maternal mortality rates, mostly attributable to puerperal fever, were substantially higher in one clinic compared with the other (16% versus 7%). He also noted that doctors and medical students often went directly to the delivery suite after performing autopsies and had a disagreeable odour on their hands despite handwashing with soap and water before entering the clinic. He hypothesized therefore that “cadaverous particles” were transmitted via the hands of doctors and students from the autopsy room to the delivery theatre and caused the puerperal fever. As a consequence, Semmelweis recommended that hands be scrubbed in a chlorinated lime solution before every patient contact and particularly after leaving the autopsy room. Following the implementation of this measure, the mortality rate fell dramatically to 3% in the clinic most affected and remained low thereafter.
Infection control: the story begins
-
4
Percentage of resistant isolates among isolates from HAIs with known antimicrobial susceptibility testing (AST) results, by species and by country, ECDC PPS 2011–12
-
Infection control: scope of interventions
In the wards…the standard of care
-
Contamination of Stethoscopes and Physicians’ Hands After a Physical Examination.
Y Longtin et al, Mayo Clin Proc 2014;89: 291-299
-
Se la flora microbica presente sulle mani si vedesse così,
non ci sarebbero le infezioni associate all’assistenza.
-
Infection control: scope of interventions
Surgical site infections
-
MRSA rates and hand hygiene compliance by quarter ; Scotland
0
10
20
30
40
50
60
70
80
90
100
Jan
07-M
ar 0
7
Apr 0
7-Ju
n 07
Jul 0
7-Se
p 07
Oct 0
7-Dec
07
Jan
08-M
ar 0
8
Apr 0
8-Ju
n 08
Jul 0
8-Se
p 08
Oct 0
8-Dec
08
Jan
09-M
ar 0
9
Apr 0
9-Ju
n 09
Jul 0
9-Se
p 09
Oct 0
9-Dec
09
Jan
10-M
ar 1
0
Apr 1
0-Ju
n 10
Jul 1
0-Se
p 10
Oct 1
0-Dec
10
Jan
11-M
ar 1
1
Han
d h
yg
ien
e %
co
mp
lian
ce
0.00
0.05
0.10
0.15
0.20
0.25
MR
SA
rate
per
1000 o
ccu
pie
d b
ed
s
HH compliance
MRSAR= -0.847
-
THE EQUATION OF THE INFECTIOUS RISK
BACTERIAL LOAD x VIRULENCE
HOST IMMUNITY
= INFECTIOUS RISK
+ DRUG RESISTANCE
HOST IMMUNITY
= INFECTIOUS RISK
Every Operation is an Experiment in Bacteriology
-
Surgical Antimicrobial Prophylaxis - definition
Surgical AMP refers to a very brief course of an antimicrobial agent initiated just before an operation begins. AMP is not an attempt to sterilize tissues, but a critically timed adjunct used to reduce the microbial burden of intra-operative contamination to a level that cannot overwhelm host defenses.
-
Prevention of SSI’s
Perioperative antimicrobial prevention measures
Maintain normal blood sugar levels
Hyper oxygenation
Maintain normal body temperature
Hair removal immediately prior to operation using electric clippers
Hand washing
Good surgical technique
Control of host-related risk factors
Antibiotics Antibiotics
-
THE FIVE MAIN TOPICS OF SURGICAL ANTIBIOTIC PROPHYAXIS
• INDICATION
• TIMING OF ADMINISTRATION
• OVERALL LENGHT OF ADMINISTRATION
• DRUG DOSAGE
• DRUG CHOICE
-
NRC Wound Classification
Clean Surgical Procedures NO PROPHYLAXIS Clean Contimated Procedures PROPHYLAXIS Contaminated Procedures THERAPY Dirty Procedures THERAPY
-
Two well recognized AMP indications for such clean operations are:
1. Any intravascular prosthetic material or prosthetic joint will be
inserted
2. Any operation in which an incisional or organ space SSI would
pose catastrophic risk
Cardiac surgery
Neurosurgical Operations
Prosthetic arterial grafts
Revascularization of lower extremity
-
THE FIVE MAIN TOPICS OF SURGICAL ANTIBIOTIC PROPHYAXIS
• INDICATION
• TIMING OF ADMINISTRATION
• OVERALL LENGHT OF ADMINISTRATION
• DRUG DOSAGE
• DRUG CHOICE
-
CINETICA di CRESCITA BATTERICA
dopo CONTAMINAZIONE INTRA-OPERATORIA
Popolazione batterica UFC/mL
PROCEDURA CHIRURGICA
TEMPO
2 -6 ore 3 -5 giorni
contaminazione
colonizzazione
INFEZIONE
-
Periodo vulnerabile
Troppo precoce Timing corretto Troppo tardiva
100
10
1
Incisione cutanea
MIC
Siero
Interstizio tessuti
C>MIC per tutto l’intervento
TIMING
-
Methods. Data about SSI and potential prophylaxis-, patient-, and procedure-related risk factors were prospectively collected for 1922 patients who underwent elective total hip arthroplasty in 11 hospitals that participated in the Dutch intervention project, Surgical Prophylaxis and Surveillance. Multivariate logistic regression analysis was performed to correct for random variation among hospitals.
The association between the timing of administration of prophylaxis and the incidence of SSI
Overall infection rate: 2.6%
Antibiotic Prophylaxis and the Risk of Surgical Site Infections following Total Hip Arthroplasty: Timely Administration Is the Most Important Factor van Kasteren MEE et al, Clin Infect Dis 2007; 44:921–7
-
THE FIVE MAIN TOPICS OF SURGICAL ANTIBIOTIC PROPHYAXIS
• INDICATION
• TIMING OF ADMINISTRATION
• OVERALL LENGHT OF ADMINISTRATION
• DRUG DOSAGE
• DRUG CHOICE
-
Implementing 1-Dose Antibiotic Prophylaxis for Prevention of Surgical Site Infection Nunes S et al, Arch Surg. 2006;141:1109-1113
Patients: Surgery was performed on 6140 consecutive patients from February 2002 through October 2002 (period 1) and 6159 consecutive patients from December 2002 through August 2003 (period 2). Studied surgeries included orthopedic, gastrointestinal, urology, vascular, lung, head and neck, heart, gynecologic, oncology, colon, neurologic, and pediatric surgeries. Intervention: Decreasing the 24-hour prophylactic antibiotic regimen to 1-dose antibiotic prophylaxis. Main Outcome Measures: Surgical site infections in both periods measured by in-hospital surveillance and Post-discharge surveillance; compliance with 1-dose prophylaxis; and costs with cephazolin.
1° period (24 h prophylaxis)
6140 surgical procedures
2° period (single dose)
6159 surgical procedures
SSI rates (%) 2 2,1
-
THE FIVE MAIN TOPICS OF SURGICAL ANTIBIOTIC PROPHYAXIS
• INDICATION
• TIMING OF ADMINISTRATION
• OVERALL LENGHT OF ADMINISTRATION
• DRUG DOSAGE
• DRUG CHOICE
-
2013
-
Vaginal preparation with povidone-iodine solution immediately before
cesarean delivery reduces the risk of postoperative endometritis.
This benefit is particularly realized for women undergoing cesarean delivery
with ruptured membranes.
As a simple, generally inexpensive intervention, providers should consider
implementing preoperative vaginal cleansing with povidone-iodine before
performing cesarean deliveries.
-
SEVERE SEPSIS
SEPSIS
T° > 38.3 / < 36°C
pulse rate > 90 beats/minute
respiratory rate > 20 breaths/min
WBC > 12.000 / < 4.000/mmc
glycemia > 120 mg/dL
lactemia > 2 mmol/L
plasma C-reactive protein >2 SD above the normal value
plasma procalcitonin > 2 SD above the normal value
refilling > 2 seconds
altered mental status
hypotension (systolic < 90 mmHg)
lactemia > 4 mmol/L
organ disfunction/s
hypotension despite 20-40 ml/kg 1^h
SEPSIS DEFINITION
SEPTIC SHOCK
-
organ dysfunction /s
Laboratories that will suggest organ dysfunction include …
PaO2 (mm Hg)/Fio2 2.0 mg/dL or Creatinine increase >0.5 mg/dL,
INR> 1.5,
PTT> 60 seconds,
Platelets < 100,000/mL,
Total bilirubin> 4 mg/dL,
Glasgow Coma Scale score < 13,
-
The clinical value of a correct antimicrobial choice
IN ORDER TO GUARANTEE THE BEST ANTIMICROBIAL OPTIONS
EPIDEMIOLOGICAL DRIVEN EMPIRICAL THERAPY
PK/PD DRIVEN THERAPY
TARGETED THERAPY AS SOON AS POSSIBLE
DON’T FORGET MICROBIOLOGICAL SPECIMENS
-
PATIENT’S CLINICAL CONDITION
RISK FACTORS FOR SPECIFIC MICROORGANISM and/or RESISTENCE PATTERNS
THE DECISION TREE…
SOURCE
PRESUMED MICROBIOLOGY
CLINICAL SEVERITY
LOCALIZATION of LESIONS
FEASIBILITY of CONTROL SOURCE
RISK FACTORS for MAJOR RESISTANCE PATTERNS
-
Sepsi Ampicillina 2 gr ogni 4-6 ore oppure Ceftriaxone 2 gr /die oppure Piperacillina sodica /tazobactam: dose carico 8+1 gr (in 1 ora); mantenimento 4 gr + 0.5 gr ogni 6 ore (infondere ogni dose in 4 ore). Sepsi severa Piperacillina sodica /tazobactam: dose di carico di 9 gr in 1 h; mantenimento con 18 gr in IC/24 h, iniziando l’infusione dopo la fine della dose di carico + Teicoplanina 12-15 mg/Kg di peso ogni 12 ore per le prime 4 dosi; a seguire 8-10 mg/Kg di peso ogni 24 ore, previa determinazione della concentrazione ematica (Cmin) del farmaco (20-30 mg /L)
-
INFEZIONI CUTANEE SUPERFICIALI
INFEZIONI CUTANEE PROFONDE NON NECROTIZZANTI
NECROTIZZANTI
INFEZIONI NECROTIZZANTI ESTESE AI TESSUTI MOLLI (fasce/muscoli)
INFEZIONI nei SOGGETTI IMMUNOCOMPROMESSI
SIRS PRESENTE SIRS ASSENTE
La terapia sistemica è accessoria
La terapia sistemica è necessaria Le scelte devono privilegiare la semplicità
La terapia sistemica è necessaria Le scelte possono basarsi sulla semplicità
La terapia sistemica è fondamentale e deve essere di massima performance
-
Ten days after an uncomplicated vaginal delivery at home, a 35-year-old woman presented to the ED with a 16 h history of severe, burning right breast pain, and 2 h of diarrhoea and vomiting. On examination, her temperature was 37.9°C, she was tachycardic (120/min), and her blood pressure was 100/70 mm Hg. Her chest was clear, with oxygen saturation 96% on air. Blood tests showed aleucocytosis of 11・3×10⁹/L and a high C-reactive protein (CRP) of 61 mg/L. The diagnosis was mastitis. Despite two intravenous doses of amoxi/clav acid, her pain worsened and the erythema continued to extend. Over the next 8 h, pain prevented her from breastfeeding; she was hypotensive and had rigors and persisting pyrexia (38.0°C). Blood tests showed leucocytosis (12・5×10⁹/L) and high CRP (183 mg/L) and creatine kinase (150 IU/L).
-
NECROTIZING
SKIN / SOFT TISSUE INFECTION
SUSPICION!
PAIN DISPROPORTIONATE TO SKIN CLINICAL FINDINGS
NOT DEMARCATE, RAPIDLY EVOLVING LESION
-
Intravenous clindamycin (2.4 g four times daily) and imipenem (1.0 g four times daily) was started according to the hospital’s protocol; IV polyspecific immunoglobulin (20 g) was also given. 11 h after presentation, our patient was transferred for emergency surgical debridement. Microbiological examination of specimens showed chains of gram-positive cocci, later yielding GAS. On day 13, her breast wound was resurfaced with a split skin graft. In December, 2003, her breast was reconstructed with a subpectoral tissue expander. When last seen in April, 2005, the patient was happy with her breast reconstruction.
Group A streptococcal necrotising fasciitis masquerading as mastitis
Tillett R L et al, Lancet 2006; 368: 174
-
83 83
100 100
14
48
4
41
%
deep infections
superficial infections
deep infections (+surgery)
superficial infections (+surgery)
clinda non clinda
Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive S. pyogenes infection. Zimbelman J et al, Pediatr Infect Dis J 1999;18:1096-100
retrospective review of the outcomes of all inpatients from 1983 to 1997 treated for invasive S. pyogenes infection at Children's Hospital. Fifty-six children were included, 37 with initially superficial disease and 19 with deep or multiple tissue infections
-
The antimicrobial therapy puzzle
The Antimicrobial Therapy Puzzle: Could Pharmacokinetic-Pharmacodynamic Relationships Be Helpful in Addressing the Issue of Appropriate Pneumonia Treatment in Critically Ill Patients?
F Pea, P Viale CID 2006;42:1764–71
-
Fabio Tumietto
Programma Aziendale Epidemiologia e Controllo del Rischio Infettivo Correlato alle Organizzazioni Sanitarie
-
Clinica Malattie Infettive - Bologna
La profilassi, la diagnosi e la scelta della terapia antibiotica
SEPSI E INFEZIONI IN GRAVIDANZA 17-18 ottobre 2014